A combinatorial biofilm treatment involving a low dose of antibiotics along with a small amount of electricity is known as the bioelectric effect (BE). When an external electric field or current is applied, biofilms can be affected by the resulting electrostatic force. Our group is researching the maximization of electrostatic force through the integration of both alternating and direct currents, with a voltage below the electrolysis threshold (0.82 V). To validate the efficacy of this technology, in the present work we investigated two major biofilm applications: (1) dentistry for oral biofilm infection and (2) hygiene for aerobic biofilm contamination. For each application, testing devices were developed in the form of a toothbrush and an evaporator cleaner, respectively. The dental clinical results demonstrated a 75% reduction in gingivitis compared to the non-BE applied group (n = 40, ANOVA, paired t-test, p < 0.05). Meanwhile, the hygiene testing result demonstrated an 81.8% increase in biofilm removal compared to the initial untreated sample (n = 6, ANOVA, paired t-test, p < 0.05). In conclusion, this new BE technology showed efficacy in both dental- and hygiene-associated biofilms without causing electrolysis. Further investigation and development of the BE system should continue in both the medical and hygiene fields.
Background Nebulizers are medical devices that deliver aerosolized medication directly to lungs to treat a variety of respiratory diseases. However, breathing patterns, respiration rates, airway diameters, and amounts of drugs delivered by nebulizers may be respiratory disease dependent. Method In this study, we developed a respiratory simulator consisting of an airway model, an artificial lung, a flow sensor, and an aerosol collecting filter. Various breathing patterns were generated using a linear actuator and an air cylinder. We tested six home nebulizers (jet (2), static (2), and vibrating mesh nebulizers (2)). Nebulizers were evaluated under two conditions, that is, for the duration of nebulization and at a constant output 1.3 mL using four breathing patterns, namely, the breathing pattern specified in ISO 27427:2013, normal adult, asthmatic, and COPD. Results One of the vibrating mesh nebulizers had the highest dose delivery efficiency. The drug delivery efficiencies of nebulizers were found to depend on breathing patterns. Conclusion We suggest a quantitative drug delivery efficiency evaluation method and calculation parameters that include considerations of constant outputs and residual volumes. The study shows output rates and breathing patterns should be considered when the drug delivery efficiencies of nebulizers are evaluated.
The functional components of vibrating mesh nebulizers are a piezoelectric ceramic with a mesh mounted on one side, a reservoir, and a driving circuit. The piezoelectric material vibrates at a specific intrinsic frequency, and when the mechanical resonance frequency of the piezoelectric ceramic and the frequency of the applied electrical signal match, the vibration amplitude of the ceramic is greatest. In the present study, nebulizing performances were tested with respect to driving voltage amplitude after automatic resonance frequency tuning (ARFT) and/or impedance matching (IM) for salbutamol and glycerol solutions. A 1% mismatch of resonance frequency reduced the output rate by 11.0~30.1% and increased particle size by 1.6~7.7% and power consumption increased by 6.6~13.6%. Driving at 30 Vpp after ARFT and IM increased output rate by 45% and decreased power consumption by 31% compared with operation at nominal resonance frequency without IM at 50 Vpp. Nebulization of viscous solutions was also enhanced by applying ARFT with IM. The study shows the application of ARFT with IM improves vibrating mesh nebulizer performance and reduces power consumption.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.